Financial Personal
Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a biopharmaceutical company committed to advancing
All dollar amounts reflected in Canadian dollars unless otherwise stated. Read More